TY - JOUR
T1 - High CA2+ intake controls cardiovascular & metabolic abnormalities of diet-induced diabetes in C57BL/6J mice
AU - Roullet, J. B.
AU - Roullet, C. M.
AU - Dolney, A. M.
AU - Phanouvong, T.
AU - McCarron, D. A.
PY - 1997
Y1 - 1997
N2 - Several studies in animals have shown that high Ca2+ intake lowers blood pressure. However, this effect of Ca2+ supplementation has not been established in non-insulin dependent (type II) diabetes, in which obesity, dyslipidemia and poor glucose/insulin control are associated with hypertension. We therefore determined the cardiovascular and metabolic consequences of increased Ca2+ intake in type II diabetes. Genetically susceptible diabetic mice (BL/6) were fed for 18 weeks either a high-fat, high-carbohydrate (HFC) or a normal (NFC) diet, and had free access to tap water (both diets contained 0.5% Ca). Another group was fed the HFC diet and drank water + 1% CaCl2 (HFC+Ca). Body weight (BW), tail-cuff systolic BP (SBP), as well as plasma cholesterol (Chol), glucose and insulin levels were determined. The results (meantSEM) were as follows: n = 9-12/group NFC HFC HFC+Ca BW, g 33.6±0.6 48.8±0.6 a 36.0±1.0 b SBP, mmHg 133±3 149±2 a 130±3 b Chol, mg/dl 82.8±8.6 173.8±15.1 a 121.1±2.6 a,b Glucose, mg/dl 137.9±12.3 247.7±21.9 a 197.2±19.5 Insulin, ng/ml 0.51±0.29 3.73±1.36 a 0.50±0.12 b a, p < 0.05 vs NFC: b, p< 0.05 vs HFC (ANOVA) We conclude that Ca2+ supplementation significantly reduces risks factors in experimental diabetes and that increasing Ca2+ intake in patients with type II diabetes may have a protective cardiovascular effect.
AB - Several studies in animals have shown that high Ca2+ intake lowers blood pressure. However, this effect of Ca2+ supplementation has not been established in non-insulin dependent (type II) diabetes, in which obesity, dyslipidemia and poor glucose/insulin control are associated with hypertension. We therefore determined the cardiovascular and metabolic consequences of increased Ca2+ intake in type II diabetes. Genetically susceptible diabetic mice (BL/6) were fed for 18 weeks either a high-fat, high-carbohydrate (HFC) or a normal (NFC) diet, and had free access to tap water (both diets contained 0.5% Ca). Another group was fed the HFC diet and drank water + 1% CaCl2 (HFC+Ca). Body weight (BW), tail-cuff systolic BP (SBP), as well as plasma cholesterol (Chol), glucose and insulin levels were determined. The results (meantSEM) were as follows: n = 9-12/group NFC HFC HFC+Ca BW, g 33.6±0.6 48.8±0.6 a 36.0±1.0 b SBP, mmHg 133±3 149±2 a 130±3 b Chol, mg/dl 82.8±8.6 173.8±15.1 a 121.1±2.6 a,b Glucose, mg/dl 137.9±12.3 247.7±21.9 a 197.2±19.5 Insulin, ng/ml 0.51±0.29 3.73±1.36 a 0.50±0.12 b a, p < 0.05 vs NFC: b, p< 0.05 vs HFC (ANOVA) We conclude that Ca2+ supplementation significantly reduces risks factors in experimental diabetes and that increasing Ca2+ intake in patients with type II diabetes may have a protective cardiovascular effect.
UR - http://www.scopus.com/inward/record.url?scp=33750271987&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33750271987&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:33750271987
SN - 0892-6638
VL - 11
SP - A468
JO - FASEB Journal
JF - FASEB Journal
IS - 3
ER -